Ligand Pharmaceuticals Inc - Net Worth and Insider Trading

Ligand Pharmaceuticals Inc Net Worth

The estimated net worth of Ligand Pharmaceuticals Inc is at least $317 Million dollars as of 2024-11-29. Ligand Pharmaceuticals Inc is the 10% Owner of Viking Therapeutics Inc and owns about 5,819,383 shares of Viking Therapeutics Inc (VKTX) stock worth over $317 Million. Details can be seen in Ligand Pharmaceuticals Inc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ligand Pharmaceuticals Inc has not made any transactions after 2020-08-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Ligand Pharmaceuticals Inc

To

Ligand Pharmaceuticals Inc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ligand Pharmaceuticals Inc owns 4 companies in total, including Pfenex Inc (PFNX) , Viking Therapeutics Inc (VKTX) , and Ligand Pharmaceuticals Inc (LGND) among others .

Click here to see the complete history of Ligand Pharmaceuticals Inc’s form 4 insider trades.

Insider Ownership Summary of Ligand Pharmaceuticals Inc

Ticker Comapny Transaction Date Type of Owner
PFNX Pfenex Inc 2020-10-01 10 percent owner
VKTX Viking Therapeutics Inc 2020-08-26 10 percent owner
LGND Ligand Pharmaceuticals Inc 2008-08-04 director
LIMIT LIMIT 2022-09-30 10 percent owner

Ligand Pharmaceuticals Inc Latest Holdings Summary

Ligand Pharmaceuticals Inc currently owns a total of 1 stock. Ligand Pharmaceuticals Inc owns 5,819,383 shares of Viking Therapeutics Inc (VKTX) as of August 26, 2020, with a value of $317 Million.

Latest Holdings of Ligand Pharmaceuticals Inc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VKTX Viking Therapeutics Inc 2020-08-26 5,819,383 54.51 317,214,567

Holding Weightings of Ligand Pharmaceuticals Inc


Ligand Pharmaceuticals Inc Form 4 Trading Tracker

According to the SEC Form 4 filings, Ligand Pharmaceuticals Inc has made a total of 2 transactions in Viking Therapeutics Inc (VKTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Viking Therapeutics Inc is the sale of 164,488 shares on August 26, 2020, which brought Ligand Pharmaceuticals Inc around $1 Million.

Insider Trading History of Ligand Pharmaceuticals Inc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ligand Pharmaceuticals Inc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ligand Pharmaceuticals Inc Ownership Network

Ownership Network List of Ligand Pharmaceuticals Inc

No Data

Ownership Network Relation of Ligand Pharmaceuticals Inc

Insider Network Chart

Ligand Pharmaceuticals Inc Owned Company Details

What does Pfenex Inc do?

Who are the key executives at Pfenex Inc?

Ligand Pharmaceuticals Inc is the 10 percent owner of Pfenex Inc. Other key executives at Pfenex Inc include director & See Remarks Evert B. Schimmelpennink , Chief Operating Officer Shawn Scranton , and Chief Scientific Officer Martin Brenner .

Pfenex Inc (PFNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pfenex Inc (PFNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pfenex Inc (PFNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pfenex Inc (PFNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Pfenex Inc Insider Transactions

No Available Data

Ligand Pharmaceuticals Inc Mailing Address

Above is the net worth, insider trading, and ownership report for Ligand Pharmaceuticals Inc. You might contact Ligand Pharmaceuticals Inc via mailing address: 3911 Sorrento Valley Blvd, Suite 110, San Diego Ca 92121.

Discussions on Ligand Pharmaceuticals Inc

No discussions yet.